Production (Stage)
Astrana Health, Inc.
ASTH
$24.29
-$0.18-0.74%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -54.89% | -156.26% | -27.04% | 45.57% | 12.97% |
Total Depreciation and Amortization | 34.40% | 65.77% | 68.73% | 75.12% | 18.73% |
Total Amortization of Deferred Charges | 50.87% | 29.71% | 92.83% | 93.67% | 93.25% |
Total Other Non-Cash Items | 18.97% | 213.66% | -48.67% | 323.34% | -2.88% |
Change in Net Operating Assets | 65.41% | -277.81% | 107.49% | -315.71% | -22.23% |
Cash from Operations | 178.18% | -156.73% | 120.58% | -10.13% | -22.58% |
Capital Expenditure | -731.98% | 64.13% | 44.09% | -12.72% | 97.52% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -1,573.88% | 81.91% | -18,367.43% | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 103.38% | 98.93% | 80.96% | -335.53% | -2,553.55% |
Cash from Investing | 96.63% | -191.63% | 76.75% | -1,441.17% | -406.16% |
Total Debt Issued | 274.55% | -100.00% | 9.89% | 51,455.56% | 6,702.72% |
Total Debt Repaid | -11,543.90% | 93.92% | -1,017.38% | -2,394.48% | -1,098.37% |
Issuance of Common Stock | -- | 92.28% | -- | -- | -- |
Repurchase of Common Stock | -- | -80.32% | -638.67% | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -5,642.11% | -- | -- | -- | -- |
Other Financing Activities | -62,050.00% | 50.46% | -125.89% | -133.29% | 125.00% |
Cash from Financing | -141.53% | -227.30% | -525.49% | 5,006.75% | 1,598.11% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -172.51% | -399.70% | 213.53% | -148.26% | 407.81% |